Names matter.
We give them to people, places, products, foods—and puppies.
Sometimes we choose a name because we love its meaning. Sometimes we wonder where a name came from. And sometimes, a name can mean very different things to different people.
Take Nimbus, for example. It was on my short list of names for a new puppy. When I heard Nimbus, I pictured dark clouds gathering before a beautiful snowstorm. My son heard Nimbus and immediately thought of the flying broomstick in Harry Potter. Nimbus was dropped from the list.
Then there are names we use every day without thinking much about their origins.
Alzheimer’s is one of those names.
Behind the name is a woman, a physician and a scientific discovery that changed how we understand memory loss.
A Name Is Just the Beginning
In 1901, German physician Alois Alzheimer met a patient named Auguste Deter at a psychiatric hospital in Frankfurt. Deter was in her early 50s and experiencing profound memory problems, confusion and changes in behavior.
Alzheimer was intrigued. Her symptoms seemed different from the forms of dementia commonly associated with older age.
He asked her a series of questions.
“What is your name?” “Auguste,” she answered.
“What is your last name” she replied “Auguste.”
“What is your husband’s name?” “Auguste, I think.”
Deter died in 1906. Alzheimer examined her brain and saw abnormalities that would become hallmarks of the disease: amyloid plaques and twisted fibers called neurofibrillary tangles, made largely of the protein tau.
That same year, Alzheimer presented his findings to colleagues.
The name stuck. The science did not.
More Than Meets the Eye
For much of the 20th century, Alzheimer’s disease was understood largely through what doctors could observe: memory loss, confusion and changes in thinking and behavior.
Gradually, neuroscience revealed a more complicated picture.
Scientists learned more about amyloid and tau. Genetics provided new clues about risk. Brain imaging offered ways to observe changes in the living brain. Researchers discovered that biological changes associated with Alzheimer’s can begin years before significant memory problems become apparent.
Today, biomarkers — including increasingly sophisticated blood tests — can detect some of these changes. These tools are helping researchers identify disease earlier and better understand how it develops.
The treatment landscape is changing, too. For some people in the early stages of Alzheimer’s, new treatments that target amyloid can slow disease progression.
Scientists are no longer looking only at whether someone is forgetting. They can increasingly investigate why.
Holding on to Memories
Alzheimer’s is not simply a story about proteins, plaques and tangles. It is a story about memories — and the people who hold them.
That is beautifully illustrated in the children’s book The Remember Balloons. A grandfather carries balloons filled with memories: his daughter as a child, his marriage, family adventures and a fishing trip with his grandson, James.
As Alzheimer’s begins to steal his memory, some balloons float away. James tries to catch them, but no matter how hard he runs, he cannot.
Confused and upset, James struggles to understand. Then his parents show him that although some of his grandfather’s balloons are gone, a new set now belongs to him.
James discovers he can keep those memories alive by sharing the stories with his grandfather. The balloons may have changed hands, but the memories — and the love behind them — can still be shared.
It is a simple, touching metaphor for something families experiencing Alzheimer’s know well: memory is precious, complicated and deeply connected to who we are.
More than 120 years after Auguste Deter became connected to the name Alzheimer’s, scientists still do not have all the answers. But we know vastly more than Alois Alzheimer did in 1906.
And that brings us back to where we began: with a name.
A name can mean different things to different people. To me, Nimbus meant snow clouds. To my son, it meant a flying broomstick. And for someone living with Alzheimer’s, a familiar name can sometimes become frustratingly difficult to retrieve.
But science is helping us understand why.
The name hasn’t changed. Our understanding has.
Happy reading,
Suzanne Daniels, Ph.D.
- In the News: insured adults are not protected from medical debt, DOL lawsuit could expand skimpy plans, and Americans want prescription drug advertising reforms.
- Mind Matters: lowering dementia risk, major brain shift between ages 50-75, and Alzheimer’s Foundation caregiver guide.
- In the Genes: the gene mutation increases lung cancer risk in non-smokers, $3.95 million price for rare disease gene therapy, and next gene-editing technology may be the oldest.
- Digging Deeper: including my personal favorite, Why Do Some Dementia Patients ‘Return’ Just Before They Die?
In the News
Healthcare Dive
Insurance doesn’t protect US adults from medical debt, Commonwealth Fund finds
HealthDay
Outcome Of Suit Against Labor Department Could Boost Skimpy Employer Health Plans
MedShadow Foundation
MedShadow Poll: Americans Want Prescription Drug Advertising Reform
Mind Matters
Associated Press
Want to lower your risk of dementia? It doesn’t involve a blood test
Science Daily
Scientists discover a major brain shift between ages 50 and 75
Connecticut Public
Caring for someone with dementia? The Alzheimer’s Foundation has a guide to help
In the Genes
Fierce Biotech
Rare EGFR mutation increases lung cancer risk 62 times in never smokers
CNBC
Ultragenyx sets $3.95 million price for rare disease gene therapy
New York Times
The Next Gene-Editing Technology May Also Be the Oldest
Digging Deeper
Smithsonian Magazine
Peptides Are All the Rage, Promising Miracle Cures and Makeovers Delivered by Injection. How Did We Get Here?
Smithsonian Magazine
Could Artificial Intelligence Help With Early Diagnosis of Schizophrenia?
New York Times
Why Do Some Dementia Patients ‘Return’ Just Before They Die?
Enjoy the weekend!
Best,
Suzanne
Suzanne Daniels, Ph.D.
AEPC President
P.O. Box 1416
Birmingham, MI 48012
Office: (248) 792-2187
Email: [email protected]

News you can trust